FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR
Taking everything into account, FRE scores 4 out of 10 in our fundamental rating. FRE was compared to 25 industry peers in the Health Care Providers & Services industry. While FRE seems to be doing ok healthwise, there are quite some concerns on its profitability. FRE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
FRE had positive earnings in 4 of the past 5 years.
In the past 5 years FRE always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 0.98%, FRE is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
FRE's Return On Equity of 2.17% is on the low side compared to the rest of the industry. FRE is outperformed by 64.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.69%, FRE is doing worse than 60.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FRE is below the industry average of 5.77%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(2.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 2.17% | ||
| ROIC | 2.69% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
The Profit Margin of FRE (1.91%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of FRE has declined.
FRE has a Operating Margin of 8.68%. This is in the better half of the industry: FRE outperforms 80.00% of its industry peers.
In the last couple of years the Operating Margin of FRE has declined.
Looking at the Gross Margin, with a value of 24.48%, FRE is in line with its industry, outperforming 48.00% of the companies in the same industry.
FRE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 1.91% | ||
| GM | 24.48% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRE is destroying value.
The number of shares outstanding for FRE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FRE has more shares outstanding
The debt/assets ratio for FRE has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.97 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.97, FRE is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
The Debt to FCF ratio of FRE is 8.76, which is on the high side as it means it would take FRE, 8.76 years of fcf income to pay off all of its debts.
FRE has a Debt to FCF ratio of 8.76. This is comparable to the rest of the industry: FRE outperforms 56.00% of its industry peers.
FRE has a Debt/Equity ratio of 0.62. This is a neutral value indicating FRE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.62, FRE is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 8.76 | ||
| Altman-Z | 1.97 |
ROIC/WACC0.54
WACC5.02%
2.3 Liquidity
FRE has a Current Ratio of 1.43. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE's Current ratio of 1.43 is fine compared to the rest of the industry. FRE outperforms 68.00% of its industry peers.
A Quick Ratio of 1.11 indicates that FRE should not have too much problems paying its short term obligations.
FRE has a better Quick ratio (1.11) than 76.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 785.11% over the past year.
FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.29% yearly.
The Revenue for FRE has decreased by -20.12% in the past year. This is quite bad
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%
3.2 Future
The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FRE is valuated correctly with a Price/Earnings ratio of 13.13.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than 80.00% of the companies in the same industry.
FRE is valuated cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.41, which indicates a very decent valuation of FRE.
FRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 80.00% of the companies in the same industry.
FRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.13 | ||
| Fwd PE | 11.41 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRE is on the same level as its industry peers.
FRE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. FRE is more expensive than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.32 | ||
| EV/EBITDA | 10.16 |
4.3 Compensation for Growth
FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.3
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.91%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.37%, FRE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.79, FRE pays a bit more dividend than its industry peers.
FRE's Dividend Yield is comparable with the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.37% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
FRE pays out 22.75% of its income as dividend. This is a sustainable payout ratio.
DP22.75%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
FRA:FRE (7/2/2025, 7:00:00 PM)
42.28
-0.36 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners36.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.81B
Analysts83.48
Price Target49.47 (17.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.37% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP22.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.13%
Min EPS beat(2)12.64%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.43%
EPS beat(12)5
Avg EPS beat(12)-43.42%
EPS beat(16)8
Avg EPS beat(16)-32.16%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.4%
Max Revenue beat(2)2.84%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.84%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)4
Avg Revenue beat(12)-0.24%
Revenue beat(16)6
Avg Revenue beat(16)-0.01%
PT rev (1m)5.98%
PT rev (3m)9.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.13 | ||
| Fwd PE | 11.41 | ||
| P/S | 1.08 | ||
| P/FCF | 15.32 | ||
| P/OCF | 9.68 | ||
| P/B | 1.23 | ||
| P/tB | 11.03 | ||
| EV/EBITDA | 10.16 |
EPS(TTM)3.22
EY7.62%
EPS(NY)3.71
Fwd EY8.77%
FCF(TTM)2.76
FCFY6.53%
OCF(TTM)4.37
OCFY10.33%
SpS39.25
BVpS34.46
TBVpS3.83
PEG (NY)1.3
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 2.17% | ||
| ROCE | 5.5% | ||
| ROIC | 2.69% | ||
| ROICexc | 3.02% | ||
| ROICexgc | 6.65% | ||
| OM | 8.68% | ||
| PM (TTM) | 1.91% | ||
| GM | 24.48% | ||
| FCFM | 7.03% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 8.76 | ||
| Debt/EBITDA | 3.91 | ||
| Cap/Depr | 77.02% | ||
| Cap/Sales | 4.09% | ||
| Interest Coverage | 4.28 | ||
| Cash Conversion | 79.5% | ||
| Profit Quality | 368.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | 1.97 |
F-Score7
WACC5.02%
ROIC/WACC0.54
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)785.11%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%31.34%
EPS Next Y10.09%
EPS Next 2Y10.97%
EPS Next 3Y9.91%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-20.12%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%-0.93%
Revenue Next Year4.95%
Revenue Next 2Y4.99%
Revenue Next 3Y5.02%
Revenue Next 5Y4.98%
EBIT growth 1Y9.47%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y16.02%
FCF growth 1Y-34.12%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-42.44%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%